XML 75 R47.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Information (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information The tables below present summarized unaudited quarterly results of operations for the years ended December 31, 2019 and 2018.

 

 

 

Quarter Ended

 

 

 

 

March 31,

 

 

June 30,

 

 

September 30,

 

 

December 31,

 

 

 

 

(In thousands except per share amounts)

 

 

2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

760,617

 

 

$

789,362

 

 

$

777,251

 

 

$

780,232

 

 

Income before income taxes

 

$

36,871

 

 

$

59,805

 

 

$

49,560

 

 

$

(10,248

)

 

Net income attributable to Acadia

Healthcare Company, Inc. stockholders

 

$

29,471

 

 

$

48,140

 

 

$

42,566

 

 

$

(11,254

)

(1)

Basic earnings per share attributable to Acadia

   Healthcare Company, Inc. stockholders

 

$

0.34

 

 

$

0.55

 

 

$

0.49

 

 

$

(0.13

)

(1)

Diluted earnings per share attributable to Acadia

   Healthcare Company, Inc. stockholders

 

$

0.34

 

 

$

0.55

 

 

$

0.48

 

 

$

(0.13

)

(1)

2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

742,241

 

 

$

765,738

 

 

$

760,916

 

 

$

743,547

 

 

Income (loss) before income taxes

 

$

48,088

 

 

$

69,258

 

 

$

55,036

 

 

$

(341,336

)

 

Net income (loss) attributable to Acadia

Healthcare Company, Inc. stockholders

 

$

50,819

 

(2)

$

58,836

 

 

$

46,232

 

 

$

(331,637

)

(3)

Basic earnings per share attributable to Acadia

   Healthcare Company, Inc. stockholders

 

$

0.58

 

(2)

$

0.67

 

 

$

0.53

 

 

$

(3.80

)

(3)

Diluted earnings per share attributable to Acadia

   Healthcare Company, Inc. stockholders

 

$

0.58

 

(2)

$

0.67

 

 

$

0.53

 

 

$

(3.80

)

(3)

 

(1)

Includes a loss on impairment of $54.4 million.

(2)

Includes tax benefits of $10.5 million pursuant to a change in the Company’s provisional amounts recorded at December 31, 2017 related to the enactment of the Tax Act. 

(3)

Includes loss on impairment of $337.9 million and legal settlements expense of $22.1 million.